Parklaan 46 B-2300 Turnhout, Belgium   +32 14 720275   info@horsten.be
CHINA
BRUSSELS

NEWS

News

16/09/2013  l  Horsten with Flemish Minister-President Kris Peeters to China
HORSTEN INTERNATIONAL PARTICIPATED IN THE BUSINESS DELEGATION TO WEST CHINA HEADED BY MINISTER-PRESIDENT KRIS PEETERS OF FLANDERS, BELGIUM From 9 to 13 September 2013 Bart Horsten participated in the business delegation to West-China headed by the Flemish Minister-President Kris Peeters. The delegation travelled to Beijing and to Chongqing and Chengdu, two major cities in the inland of China. The delegation consisted of around 60 representatives from different companies, government institutions...

> read more
09/09/2013  l  Hanjiang and Horsten sign Memorandum of Understanding
In the presence of Minister-President Kris Peeters of Flanders, Belgium, Hanjiang Investment group and Horsten International NV signed a memorandum of understanding for the establishment of a partnership for joint projects (incl.investment projects) of Belgian companies in China and Chinese companies in Belgium, in particular in the pharmaceutical and related industries. All good things come in three… After Xi'an Janssen en Xi'an Thiebaut, two very succesful cooperations between Hanjian...

> read more
09/06/2013  l  Horsten International in Gazet van Antwerpen (article in Dutch only)
Horsten International begeleidt Belgische bedrijven in China Door Bart De Bruyn, Gazet van Antwerpen Horsten International helpt bedrijven, in het bijzonder KMOs, bij het zakendoen met China. Als er een groeimarkt in de wereld is, dan is het zeker China, zegt Horsten. Het land zal binnen een tiental jaar de Verenigde Staten voorbijsteken als grootste economie ter wereld. De middenklasse in China bestaat nu al uit enkele honderden miljoenen Chinezen, en ze groeit jaarlijks nog met minstens...

> read more
18/01/2013  l  Horsten sells its shares in Vemedia Pharma
IK INVESTMENT ACQUIRES A MAJORITY OF VEMEDIA PHARMA Funds advised by IK Investment Parners (IK) have acquired over 99% of the shares of Vemedia Pharma NV (Vemedia), a leading European OTC producer and distributor of pharmaceuticals (and owner of among others the Valdispert brand). From the aforementioned 99% of the Vemedia shares, 78.4% was acquired by means of an agreement entered into on 11 October 2012 with the reference shareholders of Vemedia and the balance via a voluntary public take-ove...

> read more
 1